Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Desmopressin in Breast Cancer
NCT01606072Phase 2Completed
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Start
- Nov 2011
- Primary completion
- Feb 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of desmopressin in breast cancer, sponsored by Laboratorio Elea Phoenix S.A. Primary endpoint: Selection of the higher safe dose level for ensuing clinical trials up to 2 years. Started Nov 2011; status: completed.
02
Drugs
desmopressin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01606072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01606072.